Dabigatran Etexilate Mesylate: Management Before Invasive Radiology Procedures

Dabigatran etexilate mesylate (dabigatran) is a novel, orally ingested, competitive antithrombin anticoagulant recently approved for clinical use in Canada (Pradax) and the United States (Pradaxa). Guidelines or clinical protocols were sought discussing the management of dabigatran before invasive r...

Full description

Saved in:
Bibliographic Details
Published inJournal of radiology nursing Vol. 32; no. 2; pp. 66 - 69
Main Author Burbridge, Brent E.
Format Journal Article
LanguageEnglish
Published Mosby, Inc 01.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Dabigatran etexilate mesylate (dabigatran) is a novel, orally ingested, competitive antithrombin anticoagulant recently approved for clinical use in Canada (Pradax) and the United States (Pradaxa). Guidelines or clinical protocols were sought discussing the management of dabigatran before invasive radiology procedures. A literature search was performed (2002-2012) to determine if there were any publications discussing bleeding complications related to dabigatran and invasive radiology and/or any guidelines discussing the management of dabigatran before invasive radiology procedures. Five publications were identified related to the management of dabigatran before surgical or invasive procedures. There were no radiology-specific guidelines for the management of dabigatran before invasive radiology procedures. Guidelines related to surgical intervention and neurointervention were available. Dabigatran must be included in the list of medications that are screened for before invasive radiology procedures. Guidance is provided for the discontinuation of this medication before invasive radiology procedures.
AbstractList Dabigatran etexilate mesylate (dabigatran) is a novel, orally ingested, competitive antithrombin anticoagulant recently approved for clinical use in Canada (Pradax) and the United States (Pradaxa). Guidelines or clinical protocols were sought discussing the management of dabigatran before invasive radiology procedures. A literature search was performed (2002-2012) to determine if there were any publications discussing bleeding complications related to dabigatran and invasive radiology and/or any guidelines discussing the management of dabigatran before invasive radiology procedures. Five publications were identified related to the management of dabigatran before surgical or invasive procedures. There were no radiology-specific guidelines for the management of dabigatran before invasive radiology procedures. Guidelines related to surgical intervention and neurointervention were available. Dabigatran must be included in the list of medications that are screened for before invasive radiology procedures. Guidance is provided for the discontinuation of this medication before invasive radiology procedures.
Objective: Dabigatran etexilate mesylate (dabigatran) is a novel, orally ingested, competitive antithrombin anticoagulant recently approved for clinical use in Canada (Pradax) and the United States (Pradaxa). Guidelines or clinical protocols were sought discussing the management of dabigatran before invasive radiology procedures. [Copyright Elsevier B.V.]
Objective: Dabigatran etexilate mesylate (dabigatran) is a novel, orally ingested, competitive antithrombin anticoagulant recently approved for clinical use in Canada (Pradax) and the United States (Pradaxa). Guidelines or clinical protocols were sought discussing the management of dabigatran before invasive radiology procedures.
Author Burbridge, Brent E.
Author_xml – sequence: 1
  givenname: Brent E.
  surname: Burbridge
  fullname: Burbridge, Brent E.
  email: brent.burbridge@usask.ca
BookMark eNqNkD9v2zAUxInCARon-QYdNHaR8kiKlNihQOumbYD8Q5DMxLP4ZNCQSZeUjfrbR4Y7F5nuhrsD7jdnsxADMfaJQ8WB6-t1tU7owq4SwGUFogJQH9g5V0qVxnAxO_pal9DW8iOb57wGEEaDOmcPP3DpVzgmDMXNSH_9gCMV95QPR_OluMeAK9pQGIvv1MdExW3YY_Z7Kp7R-TjE1aF4SrEjt0uUL9lZj0Omq396wV5_3rwsfpd3j79uF9_uyk60zVgiSaeWSGQAsAFp-k613GGPrqllO70QjlPrlNG8Ea42Wi1N56B2vJeub-QF-3za3ab4Z0d5tBufOxoGDBR32fKporUUrXxHtAatDW_FFK1P0S7FnBP1dpv8BtPBcrBH0nZtT6TtkbQFYSfSU-3rqUbT472nZHPnKUxIfKJutC76_w-8ARUQiuM
CitedBy_id crossref_primary_10_1016_j_jradnu_2013_06_003
Cites_doi 10.1016/j.acvd.2011.09.001
10.1056/NEJMoa0906598
10.1111/j.1538-7836.2007.02748.x
10.1001/archinte.167.3.239
10.1056/NEJMoa0905561
10.3174/ajnr.A2850
10.1016/S0140-6736(07)61445-7
10.1016/j.thorsurg.2011.09.007
10.1182/blood-2009-09-241851
10.1160/TH09-11-0758
10.1161/CIRCULATIONAHA.110.004424
10.1056/NEJMc1111095
ContentType Journal Article
Copyright 2013 Association for Radiologic & Imaging Nursing
Copyright_xml – notice: 2013 Association for Radiologic & Imaging Nursing
DBID AAYXX
CITATION
ASE
FPQ
K6X
7QJ
DOI 10.1016/j.jradnu.2013.02.005
DatabaseName CrossRef
British Nursing Index
British Nursing Index (BNI) (1985 to Present)
British Nursing Index
Applied Social Sciences Index & Abstracts (ASSIA)
DatabaseTitle CrossRef
British Nursing Index
Applied Social Sciences Index and Abstracts (ASSIA)
DatabaseTitleList
Applied Social Sciences Index and Abstracts (ASSIA)
British Nursing Index
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Nursing
EISSN 1555-9912
EndPage 69
ExternalDocumentID 10_1016_j_jradnu_2013_02_005
S1546084313000552
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
6PF
7-5
71M
8P~
AABSN
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAWTL
AAXUO
ABBQC
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFS
ACJTP
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AFKWA
AFTJW
AFXBA
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AISVY
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
COPKO
CS3
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
EX3
FAFAN
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
M41
MO0
N9A
NAHTW
O-L
O9-
OAUVE
OZT
P-8
P-9
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SNC
SND
SNG
SPCBC
SSH
SSZ
T5K
WOW
~G-
AAXKI
AAYXX
AFJKZ
AKRWK
CITATION
ASE
FPQ
K6X
7QJ
ID FETCH-LOGICAL-c287t-ae3d5baee900a7039fc581dafad74380132d1e8d596172d4965b9cd04d1f3df73
IEDL.DBID AIKHN
ISSN 1546-0843
IngestDate Sat Oct 05 04:32:24 EDT 2024
Fri Oct 25 05:48:48 EDT 2024
Thu Sep 26 17:15:46 EDT 2024
Fri Feb 23 02:31:50 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Anticoagulation
Dabigatran
Vascular and interventional radiology
Guidelines
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c287t-ae3d5baee900a7039fc581dafad74380132d1e8d596172d4965b9cd04d1f3df73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PQID 1440669182
PQPubID 186187
PageCount 4
ParticipantIDs proquest_miscellaneous_1496663283
proquest_miscellaneous_1440669182
crossref_primary_10_1016_j_jradnu_2013_02_005
elsevier_sciencedirect_doi_10_1016_j_jradnu_2013_02_005
PublicationCentury 2000
PublicationDate 20130601
PublicationDateYYYYMMDD 2013-06-01
PublicationDate_xml – month: 06
  year: 2013
  text: 20130601
  day: 01
PublicationDecade 2010
PublicationTitle Journal of radiology nursing
PublicationYear 2013
Publisher Mosby, Inc
Publisher_xml – name: Mosby, Inc
References van Ryn, Stangier, Haertter, Liesenfeld, Wienen, Feuring (bib15) 2011; 103
Pradaxa (Dabigatran etexilate) Prescribers guide for stroke prevention in atrial fibrillation. Boehringer Ingelheim Ltd. Retrieved from
Cerfolio, Bryan (bib1) 2012; 22
Health Canada. Summary basis of decision Pradax. November 6, 2008. Retrieved from
Sié, Samama, Godier, Rosencher, Steib, Llau (bib13) 2011; 104
Cotton, McCarthy, Holcomb (bib4) 2011; 365
Garcia, Libby, Crowther (bib7) 2010; 115
Schulman, Kearon, Kakkar, Mismetti, Schellong, Eriksson (bib12) 2009; 361
Eriksson, Dahl, Rosencher, Kurth, Niek van Dijk, Frostick (bib5) 2007; 370
January 5, 2013
Connolly, Ezekowitz, Yusuf, Eikelboom, Oldgren, Parekh (bib2) 2009; 361
Eriksson, Dahl, Rosencher, Kurth, Niek van Dijk, Frostick (bib6) 2007; 5
Murphy, Lawler, Kavanagh (bib10) 2011; 32
(bib3) 2009; 20
White, Gruber, Feyzi, Kaatz, Tse, Husted (bib16) 2007; 167
Hankey, Eikelboom (bib8) 2011; 123
(10.1016/j.jradnu.2013.02.005_bib3) 2009; 20
Hankey (10.1016/j.jradnu.2013.02.005_bib8) 2011; 123
10.1016/j.jradnu.2013.02.005_bib9
Murphy (10.1016/j.jradnu.2013.02.005_bib10) 2011; 32
White (10.1016/j.jradnu.2013.02.005_bib16) 2007; 167
Cotton (10.1016/j.jradnu.2013.02.005_bib4) 2011; 365
Eriksson (10.1016/j.jradnu.2013.02.005_bib6) 2007; 5
Cerfolio (10.1016/j.jradnu.2013.02.005_bib1) 2012; 22
Connolly (10.1016/j.jradnu.2013.02.005_bib2) 2009; 361
Garcia (10.1016/j.jradnu.2013.02.005_bib7) 2010; 115
10.1016/j.jradnu.2013.02.005_bib11
Sié (10.1016/j.jradnu.2013.02.005_bib13) 2011; 104
Schulman (10.1016/j.jradnu.2013.02.005_bib12) 2009; 361
Eriksson (10.1016/j.jradnu.2013.02.005_bib5) 2007; 370
van Ryn (10.1016/j.jradnu.2013.02.005_bib15) 2011; 103
References_xml – volume: 104
  start-page: 669
  year: 2011
  end-page: 676
  ident: bib13
  article-title: Surgery and invasive procedures in patient on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors
  publication-title: Archives of Cardiovasc Dis
  contributor:
    fullname: Llau
– volume: 123
  start-page: 1436
  year: 2011
  end-page: 1450
  ident: bib8
  article-title: Dabigatran etexilate: A new oral thrombin inhibitor
  publication-title: Circulation
  contributor:
    fullname: Eikelboom
– volume: 32
  start-page: E195
  year: 2011
  ident: bib10
  article-title: Dabigatran
  publication-title: AJNR Am J Neuroradiol
  contributor:
    fullname: Kavanagh
– volume: 103
  start-page: 1116
  year: 2011
  end-page: 1127
  ident: bib15
  article-title: Dabigatran etexilate—A novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
  publication-title: Thromb Haemost
  contributor:
    fullname: Feuring
– volume: 365
  start-page: 2039
  year: 2011
  end-page: 2040
  ident: bib4
  article-title: Acutely injured patient on dabigatran
  publication-title: N Engl J Med
  contributor:
    fullname: Holcomb
– volume: 115
  start-page: 15
  year: 2010
  end-page: 20
  ident: bib7
  article-title: The new anticoagulants
  publication-title: Blood
  contributor:
    fullname: Crowther
– volume: 370
  start-page: 949
  year: 2007
  end-page: 956
  ident: bib5
  article-title: Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: A randomised, double-blind, non-inferiority trial
  publication-title: Lancet
  contributor:
    fullname: Frostick
– volume: 167
  start-page: 239
  year: 2007
  end-page: 245
  ident: bib16
  article-title: Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: Results from Sportif III and V
  publication-title: Archives of Internal Medicine
  contributor:
    fullname: Husted
– volume: 5
  start-page: 2178
  year: 2007
  end-page: 2185
  ident: bib6
  article-title: Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial
  publication-title: J Thromb Haemost
  contributor:
    fullname: Frostick
– volume: 361
  start-page: 2142
  year: 2009
  end-page: 2152
  ident: bib12
  article-title: Dabigatran versus warfarin in the treatment of acute venous thromboembolism
  publication-title: NEJM
  contributor:
    fullname: Eriksson
– volume: 22
  start-page: 29
  year: 2012
  end-page: 34
  ident: bib1
  article-title: The management of anticoagulants perioperatively
  publication-title: Thorac Surg Clin
  contributor:
    fullname: Bryan
– volume: 20
  start-page: S240
  year: 2009
  end-page: S249
  ident: bib3
  article-title: Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions
  publication-title: J Vasc Interv Radiol
– volume: 361
  start-page: 1139
  year: 2009
  end-page: 1151
  ident: bib2
  article-title: Dabigatran versus warfarin in patients with atrial fibrillation
  publication-title: N Engl J Med
  contributor:
    fullname: Parekh
– volume: 104
  start-page: 669
  year: 2011
  ident: 10.1016/j.jradnu.2013.02.005_bib13
  article-title: Surgery and invasive procedures in patient on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors
  publication-title: Archives of Cardiovasc Dis
  doi: 10.1016/j.acvd.2011.09.001
  contributor:
    fullname: Sié
– volume: 361
  start-page: 2142
  year: 2009
  ident: 10.1016/j.jradnu.2013.02.005_bib12
  article-title: Dabigatran versus warfarin in the treatment of acute venous thromboembolism
  publication-title: NEJM
  doi: 10.1056/NEJMoa0906598
  contributor:
    fullname: Schulman
– ident: 10.1016/j.jradnu.2013.02.005_bib11
– volume: 5
  start-page: 2178
  issue: 11
  year: 2007
  ident: 10.1016/j.jradnu.2013.02.005_bib6
  article-title: Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2007.02748.x
  contributor:
    fullname: Eriksson
– volume: 167
  start-page: 239
  year: 2007
  ident: 10.1016/j.jradnu.2013.02.005_bib16
  article-title: Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: Results from Sportif III and V
  publication-title: Archives of Internal Medicine
  doi: 10.1001/archinte.167.3.239
  contributor:
    fullname: White
– volume: 361
  start-page: 1139
  year: 2009
  ident: 10.1016/j.jradnu.2013.02.005_bib2
  article-title: Dabigatran versus warfarin in patients with atrial fibrillation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0905561
  contributor:
    fullname: Connolly
– volume: 20
  start-page: S240
  issue: 5
  year: 2009
  ident: 10.1016/j.jradnu.2013.02.005_bib3
  article-title: Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions
  publication-title: J Vasc Interv Radiol
– volume: 32
  start-page: E195
  year: 2011
  ident: 10.1016/j.jradnu.2013.02.005_bib10
  article-title: Dabigatran
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A2850
  contributor:
    fullname: Murphy
– volume: 370
  start-page: 949
  year: 2007
  ident: 10.1016/j.jradnu.2013.02.005_bib5
  article-title: Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: A randomised, double-blind, non-inferiority trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)61445-7
  contributor:
    fullname: Eriksson
– volume: 22
  start-page: 29
  year: 2012
  ident: 10.1016/j.jradnu.2013.02.005_bib1
  article-title: The management of anticoagulants perioperatively
  publication-title: Thorac Surg Clin
  doi: 10.1016/j.thorsurg.2011.09.007
  contributor:
    fullname: Cerfolio
– ident: 10.1016/j.jradnu.2013.02.005_bib9
– volume: 115
  start-page: 15
  issue: 1
  year: 2010
  ident: 10.1016/j.jradnu.2013.02.005_bib7
  article-title: The new anticoagulants
  publication-title: Blood
  doi: 10.1182/blood-2009-09-241851
  contributor:
    fullname: Garcia
– volume: 103
  start-page: 1116
  year: 2011
  ident: 10.1016/j.jradnu.2013.02.005_bib15
  article-title: Dabigatran etexilate—A novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
  publication-title: Thromb Haemost
  doi: 10.1160/TH09-11-0758
  contributor:
    fullname: van Ryn
– volume: 123
  start-page: 1436
  year: 2011
  ident: 10.1016/j.jradnu.2013.02.005_bib8
  article-title: Dabigatran etexilate: A new oral thrombin inhibitor
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.004424
  contributor:
    fullname: Hankey
– volume: 365
  start-page: 2039
  issue: 21
  year: 2011
  ident: 10.1016/j.jradnu.2013.02.005_bib4
  article-title: Acutely injured patient on dabigatran
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1111095
  contributor:
    fullname: Cotton
SSID ssj0029605
Score 1.909
SecondaryResourceType review_article
Snippet Dabigatran etexilate mesylate (dabigatran) is a novel, orally ingested, competitive antithrombin anticoagulant recently approved for clinical use in Canada...
Objective: Dabigatran etexilate mesylate (dabigatran) is a novel, orally ingested, competitive antithrombin anticoagulant recently approved for clinical use in...
SourceID proquest
crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 66
SubjectTerms Anticoagulation
Canada
Clinical guidelines
Dabigatran
Guidelines
Invasive
Radiology
Vascular and interventional radiology
Title Dabigatran Etexilate Mesylate: Management Before Invasive Radiology Procedures
URI https://dx.doi.org/10.1016/j.jradnu.2013.02.005
https://search.proquest.com/docview/1440669182
https://search.proquest.com/docview/1496663283
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7MieKLeMXriOBrXds0vfg2p7KpG-IFfAtpcwobUsfWib742z1ZW0VBBd9KSSB8Sc75Ps4lAIdJFGon5Z6lHCSBEsSpFXIUlhaBdhKuiJWbeude3-_cexcP4qEG7aoWxqRVlra_sOkza13-aZZoNkeDQfOWnL9vh-QAuSEeguzwPLkjN6zDfKt72el_6K6oKI80400bU15V0M3SvIZjpbOpyfHiRfNO8ZOH-marZw7ofAWWS-bIWsXiVqGG2Ros9srY-BoslMJ_HfqnKjadM8gNsbMcXwaPRChZDyev5uOYfaa8sBMk0oqsmz0rk8fObpQu6lfYrIJAT0mNb8D9-dldu2OV7yZYCemf3FLItYgVYmTbim50lCaCaKlKlQ5Mg3kSoNrBUIvI0BdtOsbHUaJtz-yaTgO-CfXsKcMtYDxAtD0UfspDT3MR2akWpFhi7scqdXEbrAorOSraY8gqb2woC2ylwVbariRstyGoAJVftlmSBf9j5kGFv6QbYMIaKsOn6USa8LTvRySUfhtDss7nxKV2_r2CXVhyi7cwLNvZg3o-nuI-MZI8bsDc0ZvToHPXvrm6bpTn7x3KNeHi
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5Ki4-LaFWszxW8hibdbB7eam1pbdODttDbsslOoEXS0jai_97ZJlEUVPAWwgaWbzMz38c8lpCbyPeUFTPbkBagQHHD2PAYcENxV1kRk8jKdb9zMHS6Y_thwicl0ip6YXRZZe77M5--8db5m3qOZn0xndafMPg7pocBkGniwdEPV5AN-GidlWav3x1-6C4_a4_U6_UYU1Z00G3KvGZLqZJU13ixbHgn_ylCffPVmwDU2Sd7OXOkzWxzB6QESZVsB3luvEq2cuF_SIb3MtSTMzAM0fYaXqfPSChpAKs3_XBLP0te6B0gaQXaS16krmOnj1Jl_St000GgUlTjR2TcaY9aXSO_N8GIUP-sDQlM8VAC-KYp0aL9OOJIS2UslasHzKMAVRZ4ivuavig9MT70I2Xa-tRU7LJjUk7mCZwQylwA0wbuxMyzFeO-GSuOiiVkTijjBtSIUWAlFtl4DFHUjc1Ehq3Q2AqzIRDbGnELQMWXYxbowf_48rrAX6AF6LSGTGCeroROTzt47l7jtzUo6xyGXOr03zu4IjvdUTAQg96wf0Z2G9m9GIZpnZPyepnCBbKTdXiZ_33vMWLiQQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dabigatran+Etexilate+Mesylate%3A+Management+Before+Invasive+Radiology+Procedures&rft.jtitle=Journal+of+radiology+nursing&rft.au=Burbridge%2C+Brent+E.&rft.date=2013-06-01&rft.issn=1546-0843&rft.volume=32&rft.issue=2&rft.spage=66&rft.epage=69&rft_id=info:doi/10.1016%2Fj.jradnu.2013.02.005&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1546-0843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1546-0843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1546-0843&client=summon